会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • RESPIRATORY DISEASE-RELATED GENE SPECIFIC SIRNA, DOUBLE-HELICAL OLIGO RNA STRUCTURE CONTAINING SIRNA, COMPOSITON CONTAINING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE
    • 呼吸系统疾病相关的基因特异性的siRNA,用siRNA双螺旋寡RNA结构及组成以防止或呼吸系统疾病的治疗
    • EP3018209A2
    • 2016-05-11
    • EP14820458.9
    • 2014-07-04
    • Bioneer CorporationYuhan Corporation
    • CHAE, JeiwookPARK, Han OhYOON, Pyoung OhHAN, BoramKIM, Mi Na
    • C12N15/113C07H21/02A61K48/00A61P11/00
    • The present invention relates to respiratory diseases, especially to gene specific siRNA related to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease (COPD), and a highly efficient double-helical oligo RNA structure containing the same, wherein the double-helical oligo RNA structure has a structure in which hydrophilic and hydrophobic materials are bonded at the both ends of the double-helical RNA (siRNA) using a simple covalent bond or a linker-mediated covalent bond to be effectively transferred into a cell, and is converted into nanoparticles by the hydrophobic interaction of the double-helical oligo RNA structure in a solution. It is desirable that the siRNA contained in the double-helical oligo RNA structure is a siRNA specific to a CTGF, Cyr61, or Plekho1, which are genes related to respiratory diseases, particularly idiopathic pulmonary fibrosis and COPD. In addition, the present invention relates to a method for producing the double-helical oligo RNA structure and a pharmaceutical composition containing the double-helical oligo RNA structure for preventing or treating respiratory diseases, particularly idiopathic pulmonary fibrosis and COPD.
    • 本发明涉及一种呼吸性疾病,爱尤其是基因相关的特发性肺纤维化和慢性阻塞性肺病(COPD)特异siRNA,和高效率的双螺旋寡RNA结构含有相同,worin双螺旋寡RNA结构具有 在其中亲水性和疏水性材料在使用简单的共价键或接头 - 介导的共价键的双螺旋RNA(siRNA)的两端键合的结构,以有效地传递到细胞中,并通过转化成纳米颗粒 在溶液中的双螺旋寡RNA结构的疏水性相互作用。 期望做包含在双螺旋结构的低聚RNA所述siRNA是特定于CTGF,Cyr61的,或Plekho1,这是相关的呼吸系统疾病,特别是特发性肺纤维化和慢性阻塞性肺病的基因的siRNA一个。 此外,本发明涉及一种用于制造双螺旋寡RNA结构且含有用于预防或治疗呼吸系统疾病,特别是特发性肺纤维化和慢性阻塞性肺病的双螺旋寡RNA结构的药物组合物的方法。
    • 6. 发明申请
    • DRIED OLIGONUCLEOTIDE COMPOSITION AND METHOD OF PRODUCING THE SAME
    • 干燥寡核苷酸组合物及其制备方法
    • WO2007094581A1
    • 2007-08-23
    • PCT/KR2007/000662
    • 2007-02-07
    • BIONEER CORPORATIONPARK, Han OhKIM, Jae Ha
    • PARK, Han OhKIM, Jae Ha
    • C07H21/00
    • C07H21/00
    • The present invention relates to a dried oligonucleotide composition and a method for producing the same. More specifically, it relates to a dried oligonucleotide composition produced by the steps comprising adding a substance for preventing the oligonucleotide from being separated and lost, which is adhesive to a storage container containing the oligonucleotide composition, in order to prevent the oligonucleotide from being separated and lost during manufacturing and distributing the dried oligonucleotide composition, optionally adding a non-reactive dye substance, and drying the resulting solution. The dried oligonucleotide composition of the present invention can be prevented from being separated and lost during manufacturing step, or transporting step after packaging, and the presence or absence of the oligonucleotide in the storage container can be easily confirmed with naked eyes. Accordingly, unnecessary labor waste and time waste caused by the separation of the oligonucleotide upon experiment can be overcome.
    • 本发明涉及干燥的寡核苷酸组合物及其制备方法。 更具体地说,涉及通过以下步骤制备的干燥的寡核苷酸组合物:为了防止寡核苷酸分离,添加防止寡核苷酸分离和丢失的物质,其与含有寡核苷酸组合物的储存容器粘合, 在制备和分配干燥的寡核苷酸组合物期间损失,任选地加入非活性染料物质,并干燥所得溶液。 可以防止本发明的干燥的寡核苷酸组合物在制造步骤或包装后的运输步骤中分离和丢失,并且可以用肉眼容易地确认存储容器中存在或不存在寡核苷酸。 因此,可以克服由实验中的寡核苷酸分离引起的不必要的劳动力浪费和时间浪费。